William R. Ringo - 05 Jun 2025 Form 4 Insider Report for ASSEMBLY BIOSCIENCES, INC. (ASMB)

Reporting relationship: Director
Issuer ticker: ASMB
Reported as of: 05 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Jun 2025, 16:05:11 UTC
Prior SEC filing: 23 May 2025
Source filing: View source filing
Reporting owner signature: /s/ John O. Gunderson, as Attorney-in-Fact

Key filing fact

William R. Ringo filed Form 4 for ASSEMBLY BIOSCIENCES, INC. (ASMB) on 09 Jun 2025.

Key facts

This page summarizes William R. Ringo's Form 4 filing for ASSEMBLY BIOSCIENCES, INC. (ASMB).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 09 Jun 2025, 16:05.

Change

Previous filing in this sequence was filed on 23 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001238325 Primary reporting owner

RINGO WILLIAM R

Relationship: Director
Address: C/O ASSEMBLY BIOSCIENCES, INC., TWO TOWER PLACE, 7TH FLOOR, SOUTH SAN FRANCISCO
Signature: /s/ John O. Gunderson, as Attorney-in-Fact
Signature date: 09 Jun 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ASMB transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +3,500
Change %
Price: $0.000000
Shares after: 3,500
Date: 05 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,500
Exercise price: $15.81
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) June 5, 2026 and (2) the date of the Issuer's 2026 annual meeting of stockholders.